Reducing the hospitalization epidemic of chronic heart failure by disease management programs

Anna Belfiore1, Rosa Stranieri2, Maria Elena Novielli2

  • 1Clinica Medica "A. Murri" & Division Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University "Aldo Moro" Medical School, Bari, Italy. belfiore.murri@gmail.com.

PubMed

Insights

Heart failure management programs enhance patient care and reduce hospitalizations. A holistic, patient-centered approach, including telemonitoring, is crucial for lifelong management of heart failure (HF) patients.

Area of Science:

  • Cardiology
  • Public Health
  • Geriatrics

Background:

  • Chronic heart failure (HF) is a leading cause of hospitalization in Europe, with increasing rates due to population aging.
  • Hospitalization signifies a critical juncture in HF, elevating risks of re-hospitalization and mortality.
  • Effective management programs are essential to improve care quality and mitigate the hospitalization burden for HF patients.

Purpose of the Study:

  • To highlight the benefits of heart failure management programs in optimizing patient care and reducing hospitalizations.
  • To emphasize the importance of a patient-centered approach and emerging technologies like telemonitoring.
  • To advocate for lifelong, differentiated follow-up strategies for all heart failure patients.

Main Methods:

  • Review of evidence from randomized clinical trials and multidisciplinary programs.
  • Analysis of the components of effective HF management: drug optimization, patient education, early decompensation recognition, and comorbidity management.
  • Evaluation of different care settings, including community HF clinics, hospital outpatient clinics, and home-based care through telemonitoring.

Main Results:

  • HF management programs improve treatment adherence and reduce unplanned hospital readmissions.
  • Multidisciplinary programs and home-visiting demonstrate significant reductions in HF and all-cause hospitalizations and mortality.
  • Telemonitoring offers continuous home-based care, enhancing continuity for HF patients.

Conclusions:

  • A holistic, patient-centered approach is vital for optimizing HF care, considering individual patient needs.
  • Differentiated, lifelong follow-up strategies are recommended for all HF patients, tailored to their specific requirements.
  • Integrating community clinics, hospital outpatient services, and telemonitoring can create a comprehensive system of care for heart failure.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
574